S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Dynavax Regains Full Rights to Investigational TLR 7/9 Inhibitor DV1179 Following Expiration of Collaboration With GSK (2014/11/28)|
|Idera Pharmaceuticals Presents Data Supporting IMO-8400 as Novel Therapy for Genetically Defined Forms of B-Cell Lymphoma at Annual ASH Meeting (2014/12/8)|
|Idera Pharmaceuticals Announces Cancer Immunotherapy Regimen With Intratumoral IMO-2055 Demonstrated Potent and Systemic Anti-Tumor Activity in Preclinical Models (2014/12/2)|
|Idera Provides Key Updates on Clinical Development of IMO-8400 for Treatment of Waldenstrom's Macroglobulinemia (2014/12/30)|
|Dynavax Announces Webcast of R&D Day (2014/12/9)|
|Idera to Present at Two Upcoming Investor Healthcare Conferences (2015/2/23)|
|Idera Pharmaceuticals Announces Closing of Public Offering of Common Stock (2015/2/19)|
|Idera Pharmaceuticals Announces Pricing of Public Offering of Common Stock (2015/2/13)|
|Idera Pharmaceuticals Announces Proposed Public Offering of Common Stock (2015/2/9)|
|Idera Announces Appointment of Robert A. Doody Jr. as Vice President of Investor Relations and Corporate Communications (2014/12/2)|
Click above to view more mutual fund data and stats for tlr - Timberline Resources Corp.